Absorption |
Blood-Brain Barrier | BBB- | 0.6476 |
Human Intestinal Absorption | HIA+ | 0.8615 |
Caco-2 Permeability | Caco2- | 0.6669 |
P-glycoprotein Substrate | Substrate | 0.5399 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.5607 |
Non-inhibitor | 0.9620 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9123 |
Distribution |
Subcellular localization | Mitochondria | 0.5567 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7521 |
CYP450 2D6 Substrate | Non-substrate | 0.8022 |
CYP450 3A4 Substrate | Substrate | 0.5242 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7243 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7677 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8733 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7571 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8879 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8554 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9088 |
Non-inhibitor | 0.6051 |
AMES Toxicity | Non AMES toxic | 0.6312 |
Carcinogens | Carcinogens | 0.6227 |
Fish Toxicity | High FHMT | 0.9921 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9271 |
Honey Bee Toxicity | High HBT | 0.5838 |
Biodegradation | Not ready biodegradable | 0.9886 |
Acute Oral Toxicity | III | 0.6104 |
Carcinogenicity (Three-class) | Non-required | 0.6400 |